Discover / Filter / Explore

Stock screener

Find the businesses that fit your questions.

Each company's latest annual period, from SEC filings. Monetary filters use the selected currency; amounts are never converted. Companies with no annual report in the last 18 months are left out unless you include them.

463 companies

Ticker	Company	Revenue	Net income ▴	Net margin	Return on equity	Revenue growth	Diluted EPS
MBRX	Moleculin Biotech, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$33.56M	n/a	-223.6%	n/a	n/a
ABUS	Arbutus Biopharma Corp Manufacturing · Year ended 2025-12-31 · USD	$14.08M	-$33.50M	-237.9%	-43.7%	128.2%	-$0.17
BOLT	Bolt Biotherapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	$7.70M	-$33.38M	-433.7%	-125.9%	0.1%	-$17.85
IBIO	iBio, Inc. Manufacturing · Year ended 2026-06-30 · USD	$100.0K	-$33.04M	n/m	-38.6%	-75.0%	-$0.32
DMAC	DiaMedica Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$32.77M	n/a	-58.4%	n/a	n/a
GNLX	Genelux Corp Manufacturing · Year ended 2025-12-31 · USD	$8.0K	-$32.15M	n/m	-278.5%	0.0%	-$0.86
GALT	Galectin Therapeutics Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$30.84M	n/a	n/a	n/a	-$0.48
RFL	Rafael Holdings, Inc. Manufacturing · Year ended 2025-07-31 · USD	$917.0K	-$30.52M	n/m	-31.0%	44.0%	-$1.04
HURA	TuHURA Biosciences, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$30.05M	n/a	-143.6%	n/a	-$0.63
CALC	CalciMedica, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$29.56M	n/a	n/a	n/a	-$1.97
IMMX	Immix Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$29.44M	n/a	-31.4%	n/a	-$0.89
ANVS	Annovis Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$28.85M	n/a	-171.2%	n/a	-$1.40
ONCY	Oncolytics Biotech Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.76M	n/a	n/a	n/a	-$0.30
OSTX	OS Therapies Inc Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.75M	n/a	n/a	n/a	-$0.98
NRXP	NRX Pharmaceuticals, Inc. Manufacturing · Year ended 2025-12-31 · USD	$1.45M	-$28.62M	n/m	n/a	n/a	n/a
GTBP	GT Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$28.35M	n/a	-490.0%	n/a	-$6.68
KALA	Kala Bio, Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$26.98M	n/a	-385.6%	n/a	-$3.31
VTVT	vTv Therapeutics Inc. Manufacturing · Year ended 2025-12-31 · USD	$0	-$26.97M	n/a	-41.9%	-100.0%	n/a
CRVO	CervoMed Inc. Manufacturing · Year ended 2025-12-31 · USD	$4.01M	-$26.97M	-673.1%	-148.0%	-58.9%	n/a
SLS	SELLAS Life Sciences Group, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.86M	n/a	-37.9%	n/a	-$0.25
CUE	Cue Biopharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	$27.47M	-$26.60M	-96.9%	-100.6%	195.7%	-$0.28
UNCY	Unicycive Therapeutics, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.55M	n/a	-87.9%	n/a	-$1.67
YARW	Yarrow Bioscience, Inc. Manufacturing · Year ended 2025-12-31 · USD	$570.0K	-$26.48M	n/m	-95.4%	13.8%	-$0.62
NVCT	Nuvectis Pharma, Inc. Manufacturing · Year ended 2025-12-31 · USD	n/a	-$26.44M	n/a	-143.6%	n/a	-$1.32
BCTX	BriaCell Therapeutics Corp. Manufacturing · Year ended 2025-07-31 · USD	n/a	-$26.31M	n/a	-151.8%	n/a	-$62.19

Rows per page: 2550 100